To receive our monthly eNews as well as event notices and other updates, just enter your email address.
Take a moment to learn more about NYAM's activities and events on Facebook. You can also see a list of NYAM's current videos on YouTube and Vimeo. You can also follow our activities through Twitter at NYAMLIBRARY.
On January 11, Dr. Jeffrey A. Lieberman received the 26th Annual Ed Hornick Memorial Award at NYAM and delivered the Hornick Lecture on the topic of “Stopping Schizophrenia with Early Intervention: Feasible or Fantasy?” The event was co-sponsored by the NYAM Sections on Psychiatry and Pediatrics, the American Academy of Pediatrics District 2 Chapter 3, and the Society for Adolescent Psychiatry.
 |
| Jeffrey A. Borenstein, MD, Chair, NYAM Psychiatry Section; Jeffrey A. Lieberman, MD; Stephen B. Billick, MD, Secretary, NYAM Psychiatry Section. |
Historically, the approach to treating schizophrenia has evolved from institutionalization and passive support to providing increasing intensity of treatment to patients as the illness progressed and patients became more severely affected and disabled. In recent years the prospect of early detection and intervention to forestall the onset or limit the morbidity and disability associated with schizophrenia has taken hold and generated great enthusiasm. Although much remains to be done to develop the methodology and evidence for effective intervention strategies, initial results of studies show considerable promise for this strategy.
In his presentation, Dr. Lieberman described the current approaches to early detection and intervention and the application of existing knowledge to limit or prevent the morbidity of schizophrenia.
Schizophrenia is a progressive disorder that derives from a genetically mediated neurodevelopmental diathesis, Dr. Lieberman explained. The clinical deterioration and enduring nature of its morbidity is due to structural pathology in frontal and temporal regions. Antipsychotic drugs target psychosis and may prevent the progression of the disorder. Early intervention and maintenance have been shown to be effective; other stages and symptom dimensions will require new therapeutic strategies and targets.
“Early detection and intervention requires better diagnostic methods, interventions and models of service delivery,” Dr. Lieberman concluded.
Jeffrey A. Lieberman, MD, is the Lawrence C. Kolb Professor and Chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; Director, New York State Psychiatric Institute; and Psychiatrist-in-Chief, Columbia University Medical Center of the New York-Presbyterian Hospital.
Dr. Lieberman’s work has advanced the understanding of the natural history and pathophysiology of schizophrenia and the pharmacology and clinical effectiveness of antipsychotic drugs. He is the recipient of many national and international honors and awards, including the Lieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders, the Adolph Meyer Award from the American Psychiatric Association, the Research Award from the National Alliance on Mental Illness, and the Neuroscience Award from the International College of Neuropsychopharmaology. He is a member of numerous scientific organizations, including the National Academy of Sciences Institute of Medicine. He has authored more than 500 papers and articles published in the scientific literature and written and/or edited ten books on mental illness, psychopharmacology and psychiatry.
About the Ed Hornick Memorial Lecture and Award
The Ed Hornick Award is given annually to a distinguished psychiatrist, usually with an interest in adolescent psychiatry.
Dr. Hornick was a Clinical Professor of Psychiatry at the Albert Einstein School of Medicine and the Director of Inpatient Services for adolescents and adults. Later, Dr. Hornick became the Chief of Psychiatry at the Manhattan State Psychiatric Center. In 1960, he became the President of the Society for Adolescent Psychiatry, and was one of the founding members. This local NY organization gave birth to the American Society for Adolescent Psychiatry, the current national organization.
After Dr. Hornick’s death in 1984, Everett Dulit, MD chaired the Ed Hornick Memorial Lecture and Award Committee, and the event was hosted annually by the Department of Psychiatry at the Albert Einstein School of Medicine. In 2005, the Lecture and Award were transferred to the Society for Adolescent Psychiatry and the Section on Psychiatry of The New York Academy of Medicine.
Posted on January 12, 2012
Contact:
Andrew J. Martin
Director of Communications
The New York Academy of Medicine
1216 Fifth Avenue
New York, New York 10029
212-822-7285
amartin@nyam.org
Reporters: to arrange interviews with NYAM medical and urban health experts, contact
Andrew J. Martin, Director of Communications
212-822-7285 / amartin@nyam.org
Community Benefit: Innovative Models and Opportunities for New York
On March 1, 2012, the NYAM Section on Health Care Delivery will present a panel discussion on the Community Benefit standard, the legal standard for determining whether a nonprofit hospital is exempt from federal income tax, moderated by Ellen Rautenberg, President and CEO of Public Health Solutions.
Vimla Patel, Director of NYAM's Center for Cognitive Studies in Medicine and Public Health is part of IOM Committee report on Health IT and Patient Safety: Building Safer Systems for Better Care, a consensus report that outlines how health IT can help improve health care providers' performance, better communication between patients and providers, and enhance patient safety. Please click on link to read the full report.
